STRATA Skin Sciences, Inc. Announces Study Published in the Journal of Drugs in Dermatology
92% of participants achieved reduction in mPASI score of 75% or more after receiving Optimal Therapeutic Dose Therapy with the Multi-Micro Dose® diagnostic tip for the treatment of their plaque psoriasis HORSHAM, Pa. , April 06, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc.
STRATA Skin Sciences Reports Fourth Quarter and Year End 2019 Financial Results
Recurring revenues grew 12.6% in 2019 Total gross margins increased 6.9% in 2019 Global recurring revenue installed base totaled 830 systems at year end 2019 Conference call and webcast, today at 8:30 am Eastern Time HORSHAM, Pa. , March 17, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc.
STRATA Skin Sciences to Host Fourth Quarter and Year End 2019 Financial Results and Business Update Conference call on March 17
HORSHAM, Pa. , March 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences, Inc. Receives A 510(k) Clearance For Its XTRAC Momentum 308nm Excimer Laser Platform
New features include increased power range, short-hair scalp tip and on-board database to improve patient safety, treatment efficiency and ease-of-use HORSHAM, Pa. , Jan. 23, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company
STRATA Skin Sciences, Inc. Announces Preliminary Q4 FY 2019 Revenue and Key Financial Metrics
Preliminary, unaudited fourth quarter revenues in the range of $8.8 million to $8.85 million Preliminary, unaudited fourth quarter recurring revenues in the range of $6.5 million to $6.55 million Preliminary, unaudited fourth quarter revenues result in double digit growth Domestic installed base
STRATA Skin Sciences, Inc. Announces Successful Completion of Debt Refinancing
Successfully extinguishes existing debt with a new commercial bank loan facility New fixed annual interest rate of 2.79%, reduces interest rate costs by approximately $700,000 HORSHAM, Pa. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a